AFMDQ
PINK Affimed N.V.$0.0003 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0003, and at the day’s high of $0.0003
- YTD change
- +200.00%
- vs 20-day SMA
- +172.48%
- vs 200-day SMA
- -44.35%
Price ranges
Price & Performance
+0.00 (+50.00%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 99.7% away from all-time highs of $0.1000
- AFMDQ is up 200% since the beginning of the year
- AFMDQ is up 200% over the past 12 months
- AFMDQ is up 200% over the past 1 month
AFMDQ reads very good: price sits above one of the two key moving averages, the 12-month move is +200.0%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0000
- Last 5 days
- +200.00%
- vs 8-day SMA
- +100.00%
No alerts for AFMDQ in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Affimed NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of cancer immunotherapies. The company’s proprietary ROCK platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs. It operates through the Germany and USA geographical segments. The company was founded in 2000 and is headquartered in Mannheim, Germany.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
